June 14, 2010
Otsuka Pharmaceutical Co., Ltd.
Otsuka receives approval for Rapirun® H. Pylori Antibody Stick as in vitro diagnostic device on June 8, 2010
Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announce that it received approval for manufacture and marketing of Rapirun® H. Pylori Antibody Stick as an in vitro diagnostic device for the rapid detection of the H. pylori antibody in urine on June 8, 2010.
Information in this news release was current as of the original release date.